2021 annual financial data
MiNK Therapeutics 2021 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -18,606,296 USD and net income was -30,212,770 USD.
Operating cash flow was -12,827,117 USD.
Get free MiNK Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -18,606,296 USD
- Net income
- -30,212,770 USD
- Operating cash flow
- -12,827,117 USD